Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Dec;116(8):3274–3278. doi: 10.1111/j.1476-5381.1995.tb15135.x

Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.

K Kinoshita 1, Y Watanabe 1, H Asai 1, M Yamamura 1, Y Matsuoka 1
PMCID: PMC1909183  PMID: 8719807

Abstract

1. The mechanism of the anti-ataxic action of thyrotropin-releasing hormone (TRH) and its analogue. TA-0910, in the Rolling mouse Nagoya (RMN), an ataxic mutant mouse, has been investigated. 2. TRH (30 mg kg-1, i.p.) and TA-0910 (3 mg kg-1, i.p.) reduced the fall index (number of falls/spontaneous motor activity), an index of ataxia, 10-30 and 10-60 min after administration, respectively. 3. Relative local cerebral glucose utilization (LCGU) in the cerebellum and ventral tegmental area (VTA) of the rolling mouse was significantly smaller than that in normal animals. TRH (30 mg kg-1, i.p.) and TA-0910 (3 mg kg-1, i.p.) increased the relative LCGU value of the VTA but not of the cerebellum in rolling mice to the level of normal animals. 4. These results suggest that the ataxia of the rolling mouse may be due to dysfunction of the cerebellum and VTA, and that amelioration by TRH and TA-0910 could result from metabolic normalization of the VTA.

Full text

PDF
3274

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brownstein M. J., Palkovits M., Saavedra J. M., Bassiri R. M., Utiger R. D. Thyrotropin-releasing hormone in specific nuclei of rat brain. Science. 1974 Jul 19;185(4147):267–269. doi: 10.1126/science.185.4147.267. [DOI] [PubMed] [Google Scholar]
  2. Chishima S. A radioimmunoassay for TA-0910, a new metabolically stable thyrotrophin-releasing hormone analogue. J Pharm Biomed Anal. 1994 Jun;12(6):795–804. doi: 10.1016/0731-7085(94)e0007-n. [DOI] [PubMed] [Google Scholar]
  3. Hashimoto T., Fukuda N. Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat. Jpn J Pharmacol. 1990 Aug;53(4):479–486. doi: 10.1254/jjp.53.479. [DOI] [PubMed] [Google Scholar]
  4. Kardon F. C., Winokur A., Utiger R. D. Thyrotropin-releasing hormone (TRH) in rat spinal cord. Brain Res. 1977 Feb 25;122(3):578–581. doi: 10.1016/0006-8993(77)90471-1. [DOI] [PubMed] [Google Scholar]
  5. Kato M., Hosokawa S., Tobimatsu S., Kuroiwa Y. Increased local cerebral glucose utilization in the basal ganglia of the rolling mouse Nagoya. J Cereb Blood Flow Metab. 1982 Dec;2(4):385–393. doi: 10.1038/jcbfm.1982.44. [DOI] [PubMed] [Google Scholar]
  6. Kennedy C., Des Rosiers M. H., Jehle J. W., Reivich M., Sharpe F., Sokoloff L. Mapping of functional neural pathways by autoradiographic survey of local metabolic rate with (14C)deoxyglucose. Science. 1975 Mar 7;187(4179):850–853. doi: 10.1126/science.1114332. [DOI] [PubMed] [Google Scholar]
  7. Kinoshita K., Fujitsuka T., Yamamura M., Matsuoka Y. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals. Eur J Pharmacol. 1995 Feb 14;274(1-3):65–72. doi: 10.1016/0014-2999(94)00712-g. [DOI] [PubMed] [Google Scholar]
  8. LeMoal M., Stinus L., Galey D. Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp Neurol. 1976 Mar;50(3):521–535. doi: 10.1016/0014-4886(76)90024-8. [DOI] [PubMed] [Google Scholar]
  9. Mano Y., Matsui K., Toyoshima E., Ando K. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice. Acta Neurol Scand. 1986 Apr;73(4):352–358. doi: 10.1111/j.1600-0404.1986.tb03289.x. [DOI] [PubMed] [Google Scholar]
  10. Mori S., Kawahara K., Sakamoto T., Aoki M., Tomiyama T. Setting and resetting of level of postural muscle tone in decerebrate cat by stimulation of brain stem. J Neurophysiol. 1982 Sep;48(3):737–748. doi: 10.1152/jn.1982.48.3.737. [DOI] [PubMed] [Google Scholar]
  11. Mori S., Sakamoto T., Ohta Y., Takakusaki K., Matsuyama K. Site-specific postural and locomotor changes evoked in awake, freely moving intact cats by stimulating the brainstem. Brain Res. 1989 Dec 25;505(1):66–74. doi: 10.1016/0006-8993(89)90116-9. [DOI] [PubMed] [Google Scholar]
  12. Muramoto O., Ando K., Kanazawa I. Central noradrenaline metabolism in cerebellar ataxic mice. Brain Res. 1982 Apr 15;237(2):387–395. doi: 10.1016/0006-8993(82)90450-4. [DOI] [PubMed] [Google Scholar]
  13. Muramoto O., Kanazawa I., Ando K. Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse. Brain Res. 1981 Jun 29;215(1-2):295–304. doi: 10.1016/0006-8993(81)90508-4. [DOI] [PubMed] [Google Scholar]
  14. Nagai Y., Narumi S., Nagawa Y., Sakurada O., Ueno H., Ishii S. Effect of thyrotropin-releasing hormone (TRH) on local cerebral glucose utilization, by the autoradiographic 2-deoxy[14C]glucose method, in conscious and pentobarbitalized rats. J Neurochem. 1980 Oct;35(4):963–971. doi: 10.1111/j.1471-4159.1980.tb07095.x. [DOI] [PubMed] [Google Scholar]
  15. Oliver C., Eskay R. L., Ben-Jonathan N., Porter J. C. Distribution and concentration of TRH in the rat brain. Endocrinology. 1974 Aug;95(2):540–546. doi: 10.1210/endo-95-2-540. [DOI] [PubMed] [Google Scholar]
  16. POIRIER L. J. Experimental and histological study of midbrain dyskinesias. J Neurophysiol. 1960 Sep;23:534–551. doi: 10.1152/jn.1960.23.5.534. [DOI] [PubMed] [Google Scholar]
  17. Péchadre J. C., Larochelle L., Poirier L. J. Parkinsonian akinesia, rigidity and tremor in the monkey. Histopathological and neuropharmacological study. J Neurol Sci. 1976 Jun;28(2):147–157. doi: 10.1016/0022-510x(76)90100-3. [DOI] [PubMed] [Google Scholar]
  18. Renaud L. P., Martin J. B., Brazeau P. Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature. 1975 May 15;255(5505):233–235. doi: 10.1038/255233a0. [DOI] [PubMed] [Google Scholar]
  19. Sharp F. R., Kilduff T. S., Bzorgchami S., Heller H. C., Ryan A. F. The relationship of local cerebral glucose utilization to optical density ratios. Brain Res. 1983 Mar 14;263(1):97–103. doi: 10.1016/0006-8993(83)91204-0. [DOI] [PubMed] [Google Scholar]
  20. Sharp T., Bennett G. W., Marsden C. A., Tulloch I. F. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul Pept. 1984 Nov;9(4):305–315. doi: 10.1016/0167-0115(84)90083-1. [DOI] [PubMed] [Google Scholar]
  21. Sharp T., Tulloch I. F., Bennett G. W., Marsden C. A., Metcalf G., Dettmar P. W. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat. Neuropharmacology. 1984 Mar;23(3):339–348. doi: 10.1016/0028-3908(84)90197-7. [DOI] [PubMed] [Google Scholar]
  22. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 May;28(5):897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
  23. Steeves J. D., Jordan L. M. Autoradiographic demonstration of the projections from the mesencephalic locomotor region. Brain Res. 1984 Jul 30;307(1-2):263–276. doi: 10.1016/0006-8993(84)90480-3. [DOI] [PubMed] [Google Scholar]
  24. Tomoda H., Kato M., Sakata S., Shima F. Striatal dysfunction in Rolling mouse Nagoya: an electrophysiological study. J Neurol Sci. 1992 Oct;112(1-2):106–112. doi: 10.1016/0022-510x(92)90139-c. [DOI] [PubMed] [Google Scholar]
  25. Trovero F., Blanc G., Hervé D., Vézina P., Glowinski J., Tassin J. P. Contribution of an alpha 1-adrenergic receptor subtype to the expression of the "ventral tegmental area syndrome". Neuroscience. 1992;47(1):69–76. doi: 10.1016/0306-4522(92)90121-h. [DOI] [PubMed] [Google Scholar]
  26. Yamaguchi T., Kato M., Fukui M., Akazawa K. Rolling mouse Nagoya as a mutant animal model of basal ganglia dysfunction: determination of absolute rates of local cerebral glucose utilization. Brain Res. 1992 Dec 11;598(1-2):38–44. doi: 10.1016/0006-8993(92)90165-6. [DOI] [PubMed] [Google Scholar]
  27. Yamamoto M., Shimizu M. Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice. Eur J Pharmacol. 1989 Aug 3;166(3):545–547. doi: 10.1016/0014-2999(89)90373-7. [DOI] [PubMed] [Google Scholar]
  28. Yarowsky P., Kadekaro M., Sokoloff L. Frequency-dependent activation of glucose utilization in the superior cervical ganglion by electrical stimulation of cervical sympathetic trunk. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4179–4183. doi: 10.1073/pnas.80.13.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES